WA
AGN

Waverly Advisors’s Allergan plc AGN Stock Holding History

Waverly Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,112
Closed -$346K – 382
2017
Q4 		$346K Buy
2,112
+808
+62% +$145K 0.05% 182
2017
Q3 		$267K Sell
1,304
-422
-24% -$98.1K 0.06% 187
2017
Q2 		$420K Buy
1,726
+289
+20% +$67.9K 0.11% 147
2017
Q1 		$343K Sell
1,437
-79
-5% -$18.4K 0.09% 161
2016
Q4 		$318K Buy
+1,516
New +$314K 0.12% 76
2015
Q4 		– Sell
-115
Closed -$31K – 423
2015
Q3 		$31K Buy
+115
New +$35.3K 0.02% 197

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Waverly Advisors's AGN Position: Q1 2018 in Review

Waverly Advisors sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 2,112 shares — an estimated $346K sold.

Waverly Advisors first reported a position in AGN in Q3 2015 and held it in 6 quarters. The position peaked at $420K in Q2 2017. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • Waverly Advisors reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Waverly Advisors sold 2,112 Allergan plc shares in Q1 2018, an estimated $346K.
  • Waverly Advisors first reported a position in Allergan plc in Q3 2015 and held it in 6 quarters.
  • Waverly Advisors's Allergan plc position peaked at $420K in Q2 2017.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Waverly Advisors's 13F filing for Q1 2018, filed 4 May 2018.